ANALYSIS OF EFFECTIVENESS, SAFETY AND COST OF DIFFERENT DOSES OF RITUXIMAB IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Mena-Vazquez, N. [1 ]
Manrique-Arija, S. [1 ]
Ordonez-Canizares, M. C. [1 ]
Domic, C. [1 ]
Urena-Garnica, I. [1 ]
Barco, C. M. Romero [1 ]
Jimenez-Nunez, F. G. [1 ]
Rojas-Gimenez, M. [1 ]
Fuego, C. [1 ]
Cano-Garcia, L. [1 ]
Irigoyen-Oyarzabal, M. V. [1 ]
Coret, V. [1 ]
Belmonte-Lopez, A. [1 ]
Fernandez-Nebro, A. [1 ]
机构：
[1] Univ Malaga, Hosp Reg Malaga, Inst Invest Biomed Malaga IBIMA, UGC Reumatol, Malaga, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.4033
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0177
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [21] Safety of rituximab in rheumatoid arthritis
    Covelli, M.
    Sarzi-Puttini, P.
    Atzeni, F.
    Macchioni, P.
    REUMATISMO, 2010, 62 (02) : 101 - 106
  • [22] Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
    Sonja Merkesdal
    Timm Kirchhoff
    Diane Wolka
    Gunter Ladinek
    Adrian Kielhorn
    Andrea Rubbert-Roth
    The European Journal of Health Economics, 2010, 11 : 95 - 104
  • [23] Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
    Merkesdal, Sonja
    Kirchhoff, Timm
    Wolka, Diane
    Ladinek, Gunter
    Kielhorn, Adrian
    Rubbert-Roth, Andrea
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2010, 11 (01): : 95 - 104
  • [24] Statin therapy for patients with rheumatoid arthritis: A cost effectiveness analysis
    Bansback, N.
    Ara, R.
    Ward, S.
    Anis, A.
    Choi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 98 - 98
  • [25] Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration (vol 18, 50, 2016)
    Chatzidionysiou, Katerina
    Lie, Elisabeth
    Nasonov, Evgeny
    Lukina, Galina
    Hetland, Merete Lund
    Tarp, Ulrik
    Ancuta, Ioan
    Pavelka, Karel
    Nordstrom, Dan C.
    Gabay, Cem
    Canhao, Helene
    Tomsic, Matija
    van Riel, Piet L. C. M.
    Gomez-Reino, Juan
    Kvien, Tore K.
    van Vollenhoven, Ronald F.
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [26] Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
    de Avila Machado, Marina Amaral
    de Moura, Cristiano Soares
    Guerra, Steve Ferreira
    Curtis, Jeffrey R.
    Abrahamowicz, Michal
    Bernatsky, Sasha
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [27] Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study
    Marina Amaral de Ávila Machado
    Cristiano Soares de Moura
    Steve Ferreira Guerra
    Jeffrey R. Curtis
    Michal Abrahamowicz
    Sasha Bernatsky
    Arthritis Research & Therapy, 20
  • [28] Modelling of the cost-effectiveness of rituximab for treatment of rheumatoid arthritis in Italy
    De, VS
    Giuliani, G
    Diamantopoulos, A
    Brown, B
    Kielhorn, A
    VALUE IN HEALTH, 2006, 9 (03) : A26 - A26
  • [29] Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis
    van Vollenhoven, Ronald
    Haraoui, Boulos
    Emery, Paul
    Bingham, Clifton
    Keystone, Edward
    Greenwald, Maria
    Moreland, Larry W.
    Kim, D.
    Cooper, Sheldon
    Wagner, B.
    Ward, P.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1606 - 1606
  • [30] Safety of rituximab in rheumatoid arthritis: Results of a pooled analysis
    van Vollenhoven, R. F.
    Emery, P.
    Bingham, C.
    Keystone, E.
    Greenwald, M.
    Moreland, L. W.
    Kim, D.
    Cooper, S.
    Wagner, B.
    Ward, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 26 - 26
12345